Inventor · disambiguated record
Darren James Kelly
Also filed as: KELLY DARREN · KELLY DARREN J · KELLY DARREN JAMES
11 granted patents·5 pending applications·52 citations·filing 2001–2023
88Inventor score
Files withOCCURX PTY LTD5CERTA THERAPEUTICS PTY LTD2FIBROTECH THERAPEUTICS PTY LTD2KELLY DARREN JAMES2ATKINS ROBERT CHARLES1
Top patents by PatentIndex Score
16 records- 0192US11905231B1Solid forms, salts and polymorphs of anti-fibrotic compoundsCERTA THERAPEUTICS PTY LTD·Filed 2023·Granted Feb 20, 2024·1 cites·30 claims
- 0288US9062076B2Fused ring analogues of anti-fibrotic agentsWILLIAMS SPENCER JOHN·Filed 2010·Granted Jun 23, 2015·27 cites·8 claims
- 0381US9839640B2Methods of treating eye diseases associated with inflammation and vascular proliferationKELLY DARREN JAMES·Filed 2011·Granted Dec 12, 2017·6 cites·1 claims
- 0477US2024262785A1Solid Forms, Salts and Polymorphs of Anti-fibrotic CompoundsCERTA THERAPEUTICS PTY LTD·Filed 2023·Application pending·0 cites
- 0575US8624056B2Halogenated analogues of anti-fibrotic agentsKELLY DARREN JAMES·Filed 2008·Granted Jan 7, 2014·4 cites·19 claims
- 0673US8765812B2Therapeutic compoundsWILLAMS SPENCER JOHN·Filed 2007·Granted Jul 1, 2014·6 cites·10 claims
- 0772US9951087B2Fused ring analogues of anti-fibrotic agentsFIBROTECH THERAPEUTICS PTY LTD·Filed 2015·Granted Apr 24, 2018·2 cites·17 claims
- 0872US9561201B2Therapeutic compoundsFIBROTECH THERAPEUTICS PTY LTD·Filed 2014·Granted Feb 7, 2017·3 cites·13 claims
- 0968US11583535B2Methods of treating eye diseases associated with inflammation and vascular proliferationOCCURX PTY LTD·Filed 2020·Granted Feb 21, 2023·0 cites·8 claims
- 1065US10786510B2Methods of treating eye diseases associated with inflammation and vascular proliferationOCCURX PTY LTD·Filed 2017·Granted Sep 29, 2020·0 cites·1 claims
- 1165US10695353B2Methods of treating eye diseases associated with inflammation and vascular proliferationOCCURX PTY LTD·Filed 2017·Granted Jun 30, 2020·0 cites·1 claims
- 1256US2024174598A1Compounds for the treatment of disorders and salts and polymorphs thereofOCCURX PTY LTD·Filed 2022·Application pending·0 cites
- 1351US7087608B2Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathyATKINS ROBERT CHARLES·Filed 2001·Granted Aug 8, 2006·3 cites·6 claims
- 1451US2023270703A1Compounds and methods for the treatment of eye disordersOCCURX PTY LTD·Filed 2021·Application pending·0 cites
- 1542US2010292335A1Use of organic compoundsCAMPBELL DUNCAN J·Filed 2008·Application pending·0 cites
- 1640US2005124624A14-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl]-benzamide for threating ang ii-mediated diseasesFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Darren James Kelly files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →